Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125565313 | 12556531 | 3 | F | 20160424 | 20160907 | 20160714 | 20160914 | EXP | GB-TAKEDA-2016MPI006302 | TAKEDA | 68.00 | YR | M | Y | 87.00000 | KG | 20160914 | MD | GB | GB |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125565313 | 12556531 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | 2.5 MG, UNK | Y | 21602 | 2.5 | MG | INJECTION | ||||||
125565313 | 12556531 | 2 | C | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Oral | 500 MG, 1/WEEK | 0 | 500 | MG | /wk | |||||||
125565313 | 12556531 | 3 | C | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | ||||||||
125565313 | 12556531 | 4 | C | ACICLOVIR | ACYCLOVIR | 1 | Unknown | 400 MG, BID | 0 | 400 | MG | BID | |||||||
125565313 | 12556531 | 5 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | Oral | 20 MG, QD | 0 | 20 | MG | QD | |||||||
125565313 | 12556531 | 6 | C | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 50 MG, QD | 0 | 50 | MG | QD | |||||||
125565313 | 12556531 | 7 | C | COTRIMOXAZOLE | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Oral | 960 MG, BID | 0 | 960 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125565313 | 12556531 | 1 | Plasma cell myeloma |
125565313 | 12556531 | 2 | Plasma cell myeloma |
125565313 | 12556531 | 3 | Plasma cell myeloma |
125565313 | 12556531 | 4 | Prophylaxis |
125565313 | 12556531 | 5 | Prophylaxis |
125565313 | 12556531 | 6 | Prophylaxis |
125565313 | 12556531 | 7 | Prophylaxis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125565313 | 12556531 | OT |
125565313 | 12556531 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125565313 | 12556531 | Asthma | |
125565313 | 12556531 | Haemophilus infection | |
125565313 | 12556531 | Monoclonal immunoglobulin present | |
125565313 | 12556531 | Neuropathy peripheral | |
125565313 | 12556531 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125565313 | 12556531 | 1 | 201602 | 20160524 | 0 | |
125565313 | 12556531 | 2 | 201603 | 20160524 | 0 | |
125565313 | 12556531 | 3 | 201602 | 20160524 | 0 | |
125565313 | 12556531 | 4 | 201602 | 20160524 | 0 | |
125565313 | 12556531 | 5 | 201602 | 20160524 | 0 | |
125565313 | 12556531 | 6 | 201602 | 20160524 | 0 | |
125565313 | 12556531 | 7 | 201602 | 20160524 | 0 |